165 related articles for article (PubMed ID: 20683697)
1. Immunohistochemical and ultrastructural characterization of the signet-ring cell carcinoma component in a case of urothelial carcinoma of the urinary bladder.
Ohtsuki Y; Fukumoto T; Okada Y; Teratani Y; Hayashi Y; Lee GH; Furihata M
Med Mol Morphol; 2010 Jun; 43(2):96-101. PubMed ID: 20683697
[TBL] [Abstract][Full Text] [Related]
2. Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma.
Terada T
Int J Clin Exp Pathol; 2013; 6(6):1150-6. PubMed ID: 23696935
[TBL] [Abstract][Full Text] [Related]
3. Micropapillary component of urothelial carcinoma detected in transurethral resection of bladder tumor (TUR-BT) tissues: a case report.
Ohtsuki Y; Ochi K; Okada Y; Kato M; Lee GH; Furihata M
Med Mol Morphol; 2008 Jun; 41(2):113-6. PubMed ID: 18592166
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI
Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878
[TBL] [Abstract][Full Text] [Related]
5. Signet ring cell carcinoma in urine cytology: cytomorphologic findings and differential diagnosis.
Guan H; Tatsas AD; Ali SZ
Acta Cytol; 2012; 56(2):177-82. PubMed ID: 22378081
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression profiles of MUC1 and MUC2 mucins in urothelial tumors of bladder.
Gonul II; Cakir A; Sozen S
Indian J Pathol Microbiol; 2018; 61(3):350-355. PubMed ID: 30004053
[TBL] [Abstract][Full Text] [Related]
7. Differences between gastric signet-ring cell carcinoma and poorly differentiated adenocarcinoma: A comparison of histopathologic features determined by mucin core protein and trefoil factor family peptide immunohistochemistry.
Fujimoto A; Ishikawa Y; Ishii T; Yamada A; Igarashi Y; Ohmoto Y; Kaise M
Pathol Int; 2017 Aug; 67(8):398-403. PubMed ID: 28691258
[TBL] [Abstract][Full Text] [Related]
8. [Renal urothelial carcinoma mainly composed of signet-ring cells].
Povzun SA; Guseva EA; Konstantinova AM; Shelekhova KV
Arkh Patol; 2015; 77(6):50-53. PubMed ID: 26841650
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated neoexpression of the pS2 peptide and MUC5AC mucin in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
Kunze E; Krassenkova I; Fayyazi A
Histol Histopathol; 2008 May; 23(5):539-48. PubMed ID: 18283638
[TBL] [Abstract][Full Text] [Related]
10. Malignant glandular lesions and glandular differentiation in invasive/noninvasive urothelial carcinoma of the urinary bladder.
Behzatoğlu K
Ann Diagn Pathol; 2011 Dec; 15(6):422-6. PubMed ID: 21855380
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis.
Konno-Shimizu M; Yamamichi N; Inada K; Kageyama-Yahara N; Shiogama K; Takahashi Y; Asada-Hirayama I; Yamamichi-Nishina M; Nakayama C; Ono S; Kodashima S; Fujishiro M; Tsutsumi Y; Ichinose M; Koike K
PLoS One; 2013; 8(2):e56766. PubMed ID: 23451082
[TBL] [Abstract][Full Text] [Related]
12. The impact of signet-ring cell carcinoma histology on bladder cancer outcome.
Wang J; Wang FW; Kessinger A
World J Urol; 2012 Dec; 30(6):777-83. PubMed ID: 21706144
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation.
Alradhi M; Wen S; Safi M; Al-Danakh A; Wang H; Shopit A; Sun M; Fan B; Li X
Cancer Med; 2023 Feb; 12(4):3931-3951. PubMed ID: 36779496
[TBL] [Abstract][Full Text] [Related]
14. Primary pure signet-ring cell adenocarcinoma of the urinary bladder: a report of three cases with an immunohistochemical study.
Terada T
Med Oncol; 2012 Dec; 29(4):2866-9. PubMed ID: 22120516
[TBL] [Abstract][Full Text] [Related]
15. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
Leroy X; Gonzalez S; Zini L; Aubert S
Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
[TBL] [Abstract][Full Text] [Related]
16. Mucin phenotypic expression in early signet ring cell carcinoma of the stomach: its relationship with the clinicopathologic factors.
Aihara R; Mochiki E; Kamiyama Y; Kamimura H; Asao T; Kuwano H
Dig Dis Sci; 2004 Mar; 49(3):417-24. PubMed ID: 15139491
[TBL] [Abstract][Full Text] [Related]
17. GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder.
Ellis CL; Chang AG; Cimino-Mathews A; Argani P; Youssef RF; Kapur P; Montgomery EA; Epstein JI
Am J Surg Pathol; 2013 Nov; 37(11):1756-60. PubMed ID: 24061521
[TBL] [Abstract][Full Text] [Related]
18. Urothelial carcinoma with abundant myxoid stroma.
Tavora F; Epstein JI
Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
[TBL] [Abstract][Full Text] [Related]
19. Primary signet cell adenocarcinoma of bladder.
Kinra P; Rashmi SP; Alam A; Singh H; Dash SC
Indian J Pathol Microbiol; 2017; 60(4):584-586. PubMed ID: 29323081
[TBL] [Abstract][Full Text] [Related]
20. Clear cell variant of urothelial carcinoma in urinary bladder; a clinicopathological and immunohistochemical study--a case report.
Persec Z; Buković D; Peršec J; Rako D; Ljubanović D; Starčević V; Zupić T; Pavić M
Coll Antropol; 2012 Sep; 36(3):1045-7. PubMed ID: 23213970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
